Recurrent Follicular T-Cell Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent Follicular T-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma (NCT04795869) | Northwestern University | 2020-03-01 |
Track Recurrent Follicular T-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.